Published: 20 August 2024
Author(s): Manuel Sánchez Cánovas, Javier López Robles, Evdochia Adoamnei, Diego Cacho Lavin, Carmen Diaz Pedroche, Eva Coma Salvans, Teresa Quintanar Verduguez, Francisco José García Verdejo, Mónica Cejuela Solís, Silvia García Adrián, Berta Obispo Portero, Alberto Garrido Fernández, Carmen Salvador Coloma, María Purificación Martínez del Prado, Jaime Mendiola, Andres J. Muñoz Martín
Section: Original Article
TESEO registry data indicate that breast cancer ranks third in cases of cancer-associated thrombosis [1]. This cannot be solely attributed to the prevalence of malignant breast pathology, as a study [2] analyzing >14,000 tumor samples identified mutations that increase the risk of thrombosis: STK11, KRAS, CTNNB1, KEAP1, MET, and CDKN2B.
